visceral pain originating from the upper urinary tract - a randomised controlled trial on the effect of morphine and oxycodone in patients undergoing percutaneus nephrolithotomy (PCNL)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2008-003962-24-DK

Enrollment

Registered

2008-09-03

Start date

2008-10-15

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone MedDRA version: 9.1 Level: LLT Classification code 10038339 Term: Removal of kidney stone

Interventions

Trade Name: oxynorm Product Code: 9821 Pharmaceutical Form: Intravenous infusion INN or Proposed INN: OXYCODONE HYDROCHLORIDE CAS Number: 124903 Concentration unit: mg/ml milligram(s)/millilitre Conce

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: indication for PCNL age >18 years Informed written consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: malignant disase in upper urinary tract pregnancy allergic to morphine or oxynorm

Design outcomes

Primary

Measure	Time frame
Primary end point(s): pain releif after administration of morphine and oxynorm;Main Objective: To study the effects of morphine and oxycodone in patients undergoing percutaneus nephrolithithotomy (PCNL) and to gain new knowledge about pain;Secondary Objective: improved pain relief with fewer side-effects	—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026